TY - JOUR
T1 - Antibiotic stewardship: A review of successful, evidence-based primary care strategies
AU - Glasziou, Paul P
AU - Dartnell, Jonathan
AU - Biezen, Ruby
AU - Morgan, Mark
AU - Manski-Nankervis, Jo-Anne
N1 - Funding Information:
Jo-Anne Manski-Nankervis BSc (Hons), MBBS (Hons), CHIA, PhD, FRACGP, Associate Professor, Department of General Practice, Melbourne Medical School, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Vic Competing interests: PG is on the Board of Directors of Therapeutic Guidelines Limited (unpaid). JD is an employee of NPS MedicineWise, which receives funding from the Australian Government Department of Health and which has implemented programs and activities cited in this article. MM reports consulting fees from Gold Coast Primary Health Network, the Department of Health, and The Royal Australian College of General Practitioners (RACGP), payment for expert testimony in the Royal Commission into Aged Care, support for travel and expenses from the RACGP, Department of Health and Victoria University, roles in the NPS MedicineWise GP Advisory Group and the Department of Health Practice Incentive Program Data Governance Committee, as well as leadership roles within the RACGP Expert Committee for Quality Care and the National COVID-19 Clinical Evidence Task Force. JM reports membership on the Pharmaceutical Benefits Advisory Committee. Funding: PG is funded by a National Health and Medical Research Council (NHMRC) Fellowship (APP1155009), and also receives funding for NHMRC Centres of Research Excellence in Minimising Antibiotic Resistance in the Community (CRE-MARC; APP1153299). JM is funded by an MRFF Next Generation Clinician Scientist Translating Research into Practice Fellowship (APP1168265) and received RACGP Foundation Therapeutic Guidelines grant funding for a pilot quality improvement program for antimicrobial stewardship in general practice. MM was Associate Investigator for an NHMRC-funded research project about antimicrobial stewardship (CREMARC 2). Provenance and peer review: Commissioned, externally peer reviewed. Correspondence to: [email protected]
Funding Information:
PG is funded by a National Health and Medical Research Council (NHMRC) Fellowship(APP1155009), and also receives funding for NHMRCCentres of Research Excellence in MinimisingAntibiotic Resistance in the Community (CREMARC;APP1153299). JM is funded by an MRFF NextGeneration Clinician Scientist Translating Researchinto Practice Fellowship (APP1168265) and receivedRACGP Foundation Therapeutic Guidelines grantfunding for a pilot quality improvement program forantimicrobial stewardship in general practice. MMwas Associate Investigator for an NHMRC-fundedresearch project about antimicrobial stewardship(CREMARC 2)
Publisher Copyright:
© The Royal Australian College of General Practitioners 2022
PY - 2022/2/1
Y1 - 2022/2/1
N2 - BACKGROUND: Antibiotic resistance is a rising global threat with only two options for mitigation: 1) invent new antibiotics and/or 2) use current antibiotics more wisely. In Australia, the majority of antibiotic usage is in the community, hence primary care has a key role. OBJECTIVE: With no single 'magic bullet', a range of approaches is needed. The aim of this article is to describe the options and evidence in three broad categories: 1) regulatory changes such as repeats and pack sizes, 2) policy initiatives such as public campaigns, academic detailing and education and 3) clinical strategies including delayed prescribing, clinical decision support tools, practice-based audit and feedback, and patient information sheets.DISCUSSION: Australia has good antibiotic regulation and guidelines but must invest in sustained primary care stewardship programs, which should include surveillance, information for consumers, support for general practitioners and general practice training, and an ongoing evaluation and research program.
AB - BACKGROUND: Antibiotic resistance is a rising global threat with only two options for mitigation: 1) invent new antibiotics and/or 2) use current antibiotics more wisely. In Australia, the majority of antibiotic usage is in the community, hence primary care has a key role. OBJECTIVE: With no single 'magic bullet', a range of approaches is needed. The aim of this article is to describe the options and evidence in three broad categories: 1) regulatory changes such as repeats and pack sizes, 2) policy initiatives such as public campaigns, academic detailing and education and 3) clinical strategies including delayed prescribing, clinical decision support tools, practice-based audit and feedback, and patient information sheets.DISCUSSION: Australia has good antibiotic regulation and guidelines but must invest in sustained primary care stewardship programs, which should include surveillance, information for consumers, support for general practitioners and general practice training, and an ongoing evaluation and research program.
UR - http://www.scopus.com/inward/record.url?scp=85123904695&partnerID=8YFLogxK
U2 - 10.31128/AJGP-07-21-6088
DO - 10.31128/AJGP-07-21-6088
M3 - Article
C2 - 35098269
SN - 2208-7958
VL - 51
SP - 15
EP - 20
JO - Australian Journal of General Practice
JF - Australian Journal of General Practice
IS - 1-2
ER -